Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses.

about

Live imaging-based model selection reveals periodic regulation of the stochastic G1/S phase transition in vertebrate axial development Extracting Intercellular Signaling Network of Cancer Tissues using Ligand-Receptor Expression Patterns from Whole-tumor and Single-cell Transcriptomes.

P2860

Q27320281-29B69EE4-F2D6-4D70-8CB8-395B5941C74B Q38617934-CD3AB273-AF23-4F51-BCA7-07E7866CE697

P2860

Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses.

Item

http://www.wikidata.org/entity/Q38569159

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Beyond genetics in personalize ...... erogeneity of tumor responses.

@en

type

Item

label

Beyond genetics in personalize ...... erogeneity of tumor responses.

@en

prefLabel

Beyond genetics in personalize ...... erogeneity of tumor responses.

@en

P1476

Beyond genetics in personalize ...... terogeneity of tumor responses

@en

P2093

Vito Quaranta

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src)

Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data

Cancer systems biology: a network modeling perspective

A TRANSMISSIBLE AVIAN NEOPLASM. (SARCOMA OF THE COMMON FOWL.)

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

P304

221-225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PME.13.6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Darren R. Tyson

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24696699

http://www.w3.org/2001/XMLSchema#string

P932

3970774

http://www.w3.org/2001/XMLSchema#string

Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses.

about

P2860

P2860

Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932